Vijaya Kancherla1, Chen Ma2, Gerald Grant3, Henry C Lee2,4, Susan R Hintz2,4, Suzan L Carmichael2,5. 1. Department of Epidemiology, Emory University, Rollins School of Public Health, Atlanta, Georgia. 2. Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California. 3. Department of Neurosurgery, Stanford University School of Medicine, Stanford, California. 4. California Perinatal Quality Care Collaborative, Stanford, California. 5. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University, Stanford, California.
Abstract
OBJECTIVE: The aim of this study is to examine factors associated with early neonatal (death within first 7 days of birth) and infant (death during the first year of life) mortality among infants born with myelomeningocele. STUDY DESIGN: We examined linked data from the California Perinatal Quality Care Collaborative, vital records, and hospital discharge records for infants born with myelomeningocele from 2006 to 2011. Survival probability was calculated using Kaplan-Meier Product Limit method and 95% confidence intervals (CI) using Greenwood's method; Cox proportional hazard models were used to estimate unadjusted and adjusted hazard ratios (HR) and 95% CI. RESULTS: Early neonatal and first-year survival probabilities among infants born with myelomeningocele were 96.0% (95% CI: 94.1-97.3%) and 94.5% (95% CI: 92.4-96.1%), respectively. Low birthweight and having multiple co-occurring birth defects were associated with increased HRs ranging between 5 and 20, while having congenital hydrocephalus and receiving hospital transfer from the birth hospital to another hospital for myelomeningocele surgery were associated with HRs indicating a protective association with early neonatal and infant mortality. CONCLUSION: Maternal race/ethnicity and social disadvantage did not predict early neonatal and infant mortality among infants with myelomeningocele; presence of congenital hydrocephalus and the role of hospital transfer for myelomeningocele repair should be further examined. KEY POINTS: · Mortality in myelomeningocele is a concern. · Social disadvantage was not associated with death. · Hospital-based factors should be further examined. Thieme. All rights reserved.
OBJECTIVE: The aim of this study is to examine factors associated with early neonatal (death within first 7 days of birth) and infant (death during the first year of life) mortality among infants born with myelomeningocele. STUDY DESIGN: We examined linked data from the California Perinatal Quality Care Collaborative, vital records, and hospital discharge records for infants born with myelomeningocele from 2006 to 2011. Survival probability was calculated using Kaplan-Meier Product Limit method and 95% confidence intervals (CI) using Greenwood's method; Cox proportional hazard models were used to estimate unadjusted and adjusted hazard ratios (HR) and 95% CI. RESULTS: Early neonatal and first-year survival probabilities among infants born with myelomeningocele were 96.0% (95% CI: 94.1-97.3%) and 94.5% (95% CI: 92.4-96.1%), respectively. Low birthweight and having multiple co-occurring birth defects were associated with increased HRs ranging between 5 and 20, while having congenital hydrocephalus and receiving hospital transfer from the birth hospital to another hospital for myelomeningocele surgery were associated with HRs indicating a protective association with early neonatal and infant mortality. CONCLUSION: Maternal race/ethnicity and social disadvantage did not predict early neonatal and infant mortality among infants with myelomeningocele; presence of congenital hydrocephalus and the role of hospital transfer for myelomeningocele repair should be further examined. KEY POINTS: · Mortality in myelomeningocele is a concern. · Social disadvantage was not associated with death. · Hospital-based factors should be further examined. Thieme. All rights reserved.
Authors: Mikyong Shin; James E Kucik; Csaba Siffel; Chengxing Lu; Gary M Shaw; Mark A Canfield; Adolfo Correa Journal: J Pediatr Date: 2012-06-23 Impact factor: 4.406
Authors: Laura Avagliano; Valentina Massa; Timothy M George; Sarah Qureshy; Gaetano Pietro Bulfamante; Richard H Finnell Journal: Birth Defects Res Date: 2018-11-12 Impact factor: 2.344
Authors: Nelson D Pace; Anna Maria Siega-Riz; Andrew F Olshan; Nancy C Chescheir; Stephen R Cole; Tania A Desrosiers; Sarah C Tinker; Adrienne T Hoyt; Mark A Canfield; Suzan L Carmichael; Robert E Meyer Journal: Birth Defects Res Date: 2019-07-19 Impact factor: 2.344
Authors: Vijaya Kancherla; Chen Ma; Gerald Grant; Henry C Lee; Gary M Shaw; Susan R Hintz; Suzan L Carmichael Journal: Am J Perinatol Date: 2019-07-15 Impact factor: 1.862
Authors: Keila N Lopez; Wendy N Nembhard; Ying Wang; Gang Liu; James E Kucik; Glenn Copeland; Suzanne M Gilboa; Russell S Kirby; Mark Canfield Journal: Birth Defects Res Date: 2017-12-01 Impact factor: 2.344
Authors: Jennifer Williams; Cara T Mai; Joe Mulinare; Jennifer Isenburg; Timothy J Flood; Mary Ethen; Barbara Frohnert; Russell S Kirby Journal: MMWR Morb Mortal Wkly Rep Date: 2015-01-16 Impact factor: 17.586